Notice of Change of Receipt Date for RFA-HD-20-007 "The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional)"

Notice Number: NOT-HD-19-026

Key Dates
Release Date: September 9, 2019

Related Announcements
RFA-HD-20-007

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this notice is to inform interested applicants that there will be a change in receipt date for the Funding Opportunity Announcement (FOA) RFA-HD-20-007 "The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional). Specifically, the receipt date will change from September 3, 2019 to November 7, 2019.

Part 1. Overview Information

Key Dates

Currently Reads:


Open Date (Earliest Submission Date)

August 3, 2019

Application Due Date(s)

September 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.


Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

September 4, 2019

Modified to Read:


Open Date (Earliest Submission Date)

October 7, 2019

Application Due Date(s)

November 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

November 8, 2019

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Lisa M. Halvorson, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-480-1646
Email: lisa.halvorson@nih.gov